Cryan JF - Search Results

1

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.

Cryan JF, Valentino RJ, Lucki I. Cryan JF, et al. Neurosci Biobehav Rev. 2005;29(4-5):547-69. doi: 10.1016/j.neubiorev.2005.03.008. Neurosci Biobehav Rev. 2005. PMID: 15893822 Review.

2

The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat.

Cryan JF, Redmond AM, Kelly JP, Leonard BE. Cryan JF, et al. Eur Neuropsychopharmacol. 1997 May;7(2):109-14. doi: 10.1016/s0924-977x(96)00391-4. Eur Neuropsychopharmacol. 1997. PMID: 9169298

3

Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?

Cryan JF, McGrath C, Leonard BE, Norman TR. Cryan JF, et al. Eur J Pharmacol. 1998 Jul 3;352(1):23-8. doi: 10.1016/s0014-2999(98)00402-6. Eur J Pharmacol. 1998. PMID: 9718263

4

Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.

Cryan JF, McGrath C, Leonard BE, Norman TR. Cryan JF, et al. Pharmacol Biochem Behav. 1999 Jun;63(2):333-8. doi: 10.1016/s0091-3057(98)00245-7. Pharmacol Biochem Behav. 1999. PMID: 10371664

5

Metyrapone displays antidepressant-like properties in preclinical paradigms.

Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE. Healy DG, et al. Among authors: cryan jf. Psychopharmacology (Berl). 1999 Aug;145(3):303-8. doi: 10.1007/s002130051062. Psychopharmacology (Berl). 1999. PMID: 10494579

6

Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635.

Cryan JF, Kelliher P, Kelly JP, Leonard BE. Cryan JF, et al. J Psychopharmacol. 1999;13(3):278-83. doi: 10.1177/026988119901300310. J Psychopharmacol. 1999. PMID: 10512084

7

Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action.

Cryan JF, Harkin A, Naughton M, Kelly JP, Leonard BE. Cryan JF, et al. Eur J Pharmacol. 2000 Mar 3;390(3):275-85. doi: 10.1016/s0014-2999(00)00012-1. Eur J Pharmacol. 2000. PMID: 10708734

8

Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.

Cryan JF, Lucki I. Cryan JF, et al. J Pharmacol Exp Ther. 2000 Dec;295(3):1120-6. J Pharmacol Exp Ther. 2000. PMID: 11082448

9

5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test.

Cryan JF, Lucki I. Cryan JF, et al. Eur J Pharmacol. 2000 Dec 15;409(3):295-9. doi: 10.1016/s0014-2999(00)00858-x. Eur J Pharmacol. 2000. PMID: 11108824

10

Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.

Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA. Cryan JF, et al. J Pharmacol Exp Ther. 2001 Aug;298(2):651-7. J Pharmacol Exp Ther. 2001. PMID: 11454927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results